HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosine

structure given in first source; a selective A(3) adenosine receptor agonist
Also Known As:
3-IB-MECA; IB-MECA; N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide; N(6)-IBAMU
Networked: 119 relevant articles (23 outcomes, 23 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Jacobson, Kenneth A: 10 articles (07/2021 - 03/2002)
2. Bar-Yehuda, Sara: 8 articles (10/2007 - 06/2002)
3. Fishman, Pnina: 8 articles (10/2007 - 06/2002)
4. Madi, Lea: 7 articles (01/2013 - 06/2002)
5. Salvemini, Daniela: 6 articles (07/2021 - 05/2012)
6. Varani, Katia: 5 articles (01/2021 - 06/2007)
7. Shainberg, Asher: 5 articles (01/2010 - 05/2002)
8. Ochaion, Avivit: 5 articles (10/2007 - 05/2003)
9. Di Cesare Mannelli, Lorenzo: 4 articles (01/2022 - 01/2020)
10. Ghelardini, Carla: 4 articles (01/2022 - 01/2020)

Related Diseases

1. Ischemia
2. Infarction (Infarctions)
3. Myocardial Stunning (Stunned Myocardium)
4. Necrosis
5. Lung Injury

Related Drugs and Biologics

1. Purinergic P1 Receptors (Adenosine Receptor)
2. Adenosine A3 Receptor
3. Anti-Bacterial Agents (Antibiotics)
4. Adenosine A1 Receptor
5. Adenosine Triphosphate (ATP)
6. Cytokines
7. MRS 1191
8. Caspase 1 (ICE Protease)
9. Anthracyclines
10. Protein Kinase C

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Intravenous Administration
3. Therapeutics
4. Ligation
5. Oral Administration